Navigation Links
aTyr Pharma to Present at 24th Annual Credit Suisse Healthcare Conference

SAN DIEGO, Nov. 3, 2015 /PRNewswire/ -- aTyr Pharma (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases, today announced the Company's participation at the 24th Annual Credit Suisse Healthcare Conference to be held at The Phoenician in Scottsdale, AZ, November 9-11.

John Mendlein, aTyr's CEO and Executive Chairman, will provide an overview of the Company during a presentation at 7:30 a.m. MST on Wednesday, November 11, 2015.  The presentation will be webcast live through the "Investors" section of the Company website at  An audio replay will be available for 30 days following the initial presentation webcast. 

About aTyr Pharma
aTyr Pharma engages in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of Physiocrine biology, a newly discovered set of physiological modulators. The Company's lead candidate, Resolaris™, is a first-in-class intravenous protein therapeutic for the treatment of rare myopathies with an immune component (RMIC). Resolaris™ is currently in a Phase 1b/2 clinical trial in adult patients with FSHD, as well a Phase 1b/2 trial in adult patients with LGMD2B or FSHD.  Trials are planned in additional RMIC indications, including a study of patients with an early onset form of FSHD as well as an initial trial in rare pulmonary diseases with an immune component (RPIC) in patients with interstitial lung disease (ILD). To protect this pipeline, aTyr built an intellectual property estate comprising 45 issued or allowed patents and over 240 pending patent applications that are solely owned or exclusively licensed by aTyr.  aTyr's key programs are currently focused on severe, rare diseases characterized by immune dysregulation for which there are currently limited or no treatment options. For more information, please visit

SOURCE aTyr Pharma
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Isis Pharmaceuticals Reports an Update on ISIS-TTR Rx, Including Positive Data from Multiple Clinical Studies, Presented Today at the EC-ATTR Meeting
2. Active Pharmaceutical Ingredient Market to Rise At 6.5% CAGR to 2020
3. Pharmaceutical Packaging Market in North America 2015-2019
4. Global Pharmaceutical Packaging Market 2015-2019 - Reportlinker Review
5. Meijer Opens Full-Service Pharmacy Inside Butterworth Hospital
6. SoftServe Reviews Impact of 21st Century Cures Act on Pharmaceutical Sector
7. Galmed Pharmaceuticals Third Quarter 2015 Conference Call and Webcast Scheduled for November 9, 2015
8. Nicolas Sitchon, CEO of S1 Biopharma, to Present at BIO-Europe 2015 Conference
9. Harold Paz, M.D., M.S., Executive Vice President and Chief Medical Officer for Aetna Joins Speaker Lineup for 2016 Armada Specialty Pharmacy Summit
10. Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-FXI Rx in Patients with End-Stage Renal Disease on Hemodialysis
11. Oasmia Pharmaceutical Receives Order of $7.5 Million in End-user Value for the Russian Market
Post Your Comments:
(Date:6/23/2020)... ... June 23, 2020 , ... Today Project HOPE announced ... first online COVID-19 trainings for health workers and others on the frontlines of ... COVID-19 Training for Health Workers: Preparedness and Response are now live ...
(Date:6/23/2020)... ... June 23, 2020 , ... One size fits all may work for a ... similar, universal program does not work as an overall response to the virus causing ... life in one way or another, from plummeting stock markets and rising unemployment on ...
(Date:6/19/2020)... ... June 19, 2020 , ... The Covid-19 pandemic has had an undeniable ... safe environment and compliant workforce is critical in the post-Covid world. , To help ... SupplyBay vending machine below cost for a limited time only. , “We are ...
Breaking Medicine Technology:
(Date:6/28/2020)... (PRWEB) , ... June 27, 2020 , ... The secret ... folds of hundreds of rolls of toilet paper. Yet, it was the first product ... seems sensible in theory. The more you have stockpiled, the less need to venture ...
(Date:6/25/2020)... ... ... Denials Management, Inc. has just published The Health Insurance Appeals Guide to inform ... mental health and substance use disorder (MH/SUD) treatment services. It was written by leading ... steps in the appeals process. Complimentary copies of the Guide can be ...
(Date:6/24/2020)... ... 2020 , ... SPH Analytics , a leader in ... (PHO) has successfully deployed SPH’s Population Care™ all-payer population health management solution to ... of Population Care is benefitting more than 77,000 patients covered by value-based contracts ...
(Date:6/23/2020)... ... June 23, 2020 , ... Oak Street Health, a network ... further plans for nationwide expansion in 2020 with the company’s first centers in New ... two locations in Brooklyn, N.Y., and a new center in Jackson, Miss. , ...
(Date:6/23/2020)... ARLINGTON, Va. (PRWEB) , ... June 22, 2020 , ... ... Information updated market sizes and forecasts for the market for tests tied to therapeutic ... surveyed oncology treatment centers in hospitals, as well as pharmaceutical companies serving them to ...
Breaking Medicine News(10 mins):